Delayed adverse reactions to total-dose intravenous iron polymaltose

Internal Medicine Journal

Volumn 39, Issue 4, 2009, Pages 252-255

  Haines, M L ^a,b   Gibson, P R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b BOX HILL HOSPITAL   (Australia)

Author keywords

Adverse effects; Intravenous iron; Iron deficiency

Indexed keywords

IRON POLYMALTOSE;

ADULT; AGED; ARTICLE; CHILL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; FAINTNESS; FEMALE; FEVER; HEADACHE; HUMAN; INFUSION RATE; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; RASH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRALGIA; CELIAC DISEASE; FEMALE; FERRIC COMPOUNDS; FEVER; GASTROINTESTINAL DISEASES; HEADACHE; HUMANS; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; IRON; MALABSORPTION SYNDROMES; MALE; MIDDLE AGED; STOMACH DISEASES; YOUNG ADULT;

EID: 65349121774     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01898.x     Document Type: Article

References (13)

1. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000 6 : 142 50. Discussion 151.
2. Oldenburg B, van Berge Henegouwen GP, Rennick D, Van Asbeck BS, Koningsberger JC. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 2000 30 : 505 10.
3. Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003 38 : 543 8.
4. Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 2000 14 : 1163 8.
5. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992 13 : 169 81.
6. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int 2003 64 : 572 8.
7. Newnham E, Ahmad I, Thornton A, Gibson PR. Safety of iron polymaltose given as a total dose iron infusion. Intern Med J 2006 36 : 672 4.
8. Bailie GR, Lane PL, Clark JA, Stang PE, Lane CE. Safety surveillance of intravenous iron preparations - relative rates of hypersensitivity reactions reported in the USA. J Am Soc Nephrol 2003 14 : 458A.
9. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 2001 38 : 988 91.
10. Schroder O, Schrott M, Blumenstein I, Jahnel J, Dignass AU, Stein J. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. Z Gastroenterol 2004 42 : 663 7.
11. Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997 126 : 782 7.
12. Gasche C, Dejaco C, Reinisch W, Tillinger W, Waldhoer T, Fueger GF et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999 60 : 262 7.
13. Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001 96 : 2382 7.